| Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19 M Tomazou, MM Bourdakou, G Minadakis, M Zachariou, A Oulas, ... Briefings in bioinformatics 22 (6), bbab114, 2021 | 33 | 2021 |
| The impact of estradiol on serotonin, glutamate, and dopamine systems PC Bendis, S Zimmerman, A Onisiforou, P Zanos, P Georgiou Frontiers in neuroscience 18, 1348551, 2024 | 20 | 2024 |
| Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches A Onisiforou, GM Spyrou Briefings in Bioinformatics 22 (6), bbab141, 2021 | 16 | 2021 |
| Immunomodulatory effects of microbiota-derived metabolites at the crossroad of neurodegenerative diseases and viral infection: network-based bioinformatics insights A Onisiforou, GM Spyrou Frontiers in Immunology 13, 843128, 2022 | 11 | 2022 |
| Systems bioinformatics reveals possible relationship between COVID-19 and the development of neurological diseases and neuropsychiatric disorders A Onisiforou, GM Spyrou Viruses 14 (10), 2270, 2022 | 9 | 2022 |
| Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions A Onisiforou, P Georgiou, P Zanos Pharmacology Biochemistry and Behavior 223, 173531, 2023 | 8 | 2023 |
| Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data CC Christodoulou, A Onisiforou, P Zanos, EZ Papanicolaou Frontiers in Aging Neuroscience 15, 1273855, 2023 | 7 | 2023 |
| Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer’s disease A Onisiforou, CC Christodoulou, E Zamba-Papanicolaou, P Zanos, ... Frontiers in Endocrinology 15, 1345498, 2024 | 6 | 2024 |
| From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links Through Systems Bioinformatics A Onisiforou, P Zanos The Journal of Infectious Diseases 230 (Supplement 2), S128-S140, 2024 | 6 | 2024 |
| Molecular signatures of premature aging in Major Depression and Substance Use Disorders A Onisiforou, P Zanos, P Georgiou Scientific Data 11 (1), 698, 2024 | 3 | 2024 |
| (2R,6R)-hydroxynorketamine facilitates extinction and prevents emotional impairment and stress-induced reinstatement in morphine abstinent mice A Michael, A Onisiforou, P Georgiou, M Koumas, E Mammadov, P Zanos bioRxiv, 2023.12. 07.570550, 2023 | 2 | 2023 |
| Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms A Onisiforou, EG Charalambous, P Zanos Microorganisms 13 (1), 90, 2025 | 1 | 2025 |
| One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders A Onisiforou, P Zanos Computational and Structural Biotechnology Journal 23, 3610-3624, 2024 | 1 | 2024 |
| P-1855. Dissecting the contribution of Herpesviruses in the emergence of depressive symptoms in Alzheimer's Disease through multi-omics data A Onisiforou, P Zanos Open Forum Infectious Diseases 12 (Supplement_1), ofae631. 2016, 2025 | | 2025 |
| Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders A Onisiforou, A Michael, M Apostolakis, E Mammadov, A Mitka, ... Biological Psychiatry, 2024 | | 2024 |
| Network-Based Analysis Identifies Targetable Pathways in Comorbid Type II Diabetes and Neuropsychiatric Disorders A Onisiforou, P Zanos bioRxiv, 2024.06. 25.600630, 2024 | | 2024 |
| Neuroendocrine Regulation of Anxiety A Onisiforou, P Zanos, P Georgiou Anxiety Disorders and Related Conditions: Conceptualization and Treatment …, 2024 | | 2024 |
| Ketamine Metabolites as Next-Generation Pharmacotherapies for Treating Opioid Addiction A Onisiforou, A Michael, P Georgiou, E Mammadov, P Zanos NEUROPSYCHOPHARMACOLOGY 48, 481-481, 2023 | | 2023 |
| OPEN ACCESS EDITED BY F Castiglione, E Onofri, P Brigidi, GM Spyrou, A Onisiforou, GM Spyrou Quantification of immunological memory, 103, 2023 | | 2023 |
| Ketamine and hydroxynorketamine as novel pharmacotherapies for the treatment of Opioid-Use Disorders O Anna, A Michael, M Apostolakis, E Mammadov, A Mitka, MA Kalatta, ... Biological Psychiatry, 0 | | |
Panos ZanosAssistant Professor of Neuropharmacology, University of CyprusGeverifieerd e-mailadres voor ucy.ac.cy
